Amphastar Pharmaceuticals, Inc. Employee Count
The employee counts Amphastar Pharmaceuticals, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 163; Filing 2026-02-26; Lease expense per employee $62,380.37.
- 2024-12-31: Employees (as filed) 322; Filing 2025-03-03; Lease expense per employee $20,962.73.
- 2023-12-31: Employees (as filed) 308; Filing 2024-02-29; Lease expense per employee $18,938.31.
- 2022-12-31: Employees (as filed) 249; Filing 2023-03-01; Lease expense per employee $21,172.69.
- Available history
- 2014-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 163 | 2026-02-26 | $62,380.37 total lease cost |
| 2024-12-31 | 322 | 2025-03-03 | $20,962.73 total lease cost |
| 2023-12-31 | 308 | 2024-02-29 | $18,938.31 total lease cost |
| 2022-12-31 | 249 | 2023-03-01 | $21,172.69 total lease cost |
| 2021-12-31 | 245 | 2022-03-11 | $21,453.06 total lease cost |
| 2020-12-31 | 354 | 2021-03-15 | $15,522.60 total lease cost |
| 2019-12-31 | 2,027 full-time | 2020-03-16 | $2,462.26 total lease cost |
| 2018-12-31 | 2,078 full-time | 2019-03-15 | $2,021.17 lease and rental expense |
| 2017-12-31 | 290 | 2018-03-14 | $12,068.97 lease and rental expense |
| 2016-12-31 | 277 | 2017-03-15 | $12,274.37 lease and rental expense |
| 2015-12-31 | 1,460 full-time | 2016-03-15 | $2,260.27 lease and rental expense |
| 2014-12-31 | 1,361 full-time | 2015-03-26 | $2,277.74 lease and rental expense |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |